Results 251 to 260 of about 661,169 (403)

Gingival Hyperplasia

Internal Medicine
Teruya, Hiroyuki, Yano, Hiroyuki, Kinjo, Mitsuyo   +2 more
openaire   +2 more sources

Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma

Cancer Communications, EarlyView.
Katia Mariniello, James F. H. Pittaway, Barbara Altieri, Kleiton Silva Borges, Irene Hadjidemetriou, Claudio Ribeiro, Gerard Ruiz‐Babot, David S. Tourigny, Jiang A. Lim, Julie Foster, Julie Cleaver, Jane Sosabowski, Nafis Rahman, Milena Doroszko, Constanze Hantel, Sandra Sigala, Andrea Abate, Mariangela Tamburello, Katja Kiseljak‐Vassiliades, Margaret Wierman, Charlotte Hall, Laila Parvanta, Tarek E. Abdel‐Aziz, Teng‐Teng Chung, Aimee Di Marco, Fausto Palazzo, Celso E. Gomez‐Sanchez, David R. Taylor, Oliver Rayner, Cristina L. Ronchi, Carles Gaston‐Massuet, Silviu Sbiera, William M. Drake, Emanuel Rognoni, Matthias Kroiss, David T. Breault, Martin Fassnacht, Leonardo Guasti   +37 more
wiley   +1 more source

Heart failure and obesity: Translational approaches and therapeutic perspectives. A scientific statement of the Heart Failure Association of the ESC

European Journal of Heart Failure, EarlyView.
Abstract Obesity and heart failure (HF) represent two growing pandemics. In the general population, obesity affects one in eight adults and is linked with an increased risk for HF. Obesity is even more common in patients with HF, where it complicates the diagnosis of HF and is linked with worse symptoms and impaired exercise capacity. Over the past few
Gianluigi Savarese, Gabriele G. Schiattarella, Felix Lindberg, Markus S. Anker, Antoni Bayes‐Genis, Magnus Bäck, Frieder Braunschweig, Chiara Bucciarelli‐Ducci, Javed Butler, Antonio Cannata, Federico Capone, Ovidiu Chioncel, Emilia D'Elia, Arantxa González, Gerasimos Filippatos, Nicolas Girerd, Jean‐Sébastien Hulot, Carolyn S.P. Lam, Lars H. Lund, Christoph Maack, Brenda Moura, Mark C. Petrie, Massimo Piepoli, Abdullah Shehab, Mehmet B. Yilmaz, Peter Seferovic, Carlo G. Tocchetti, Giuseppe M.C. Rosano, Marco Metra   +28 more
wiley   +1 more source

A New Form of Congenital Adrenal Hyperplasia¹ [PDF]

, 1967
Maria I. New, Ralph E. Peterson
openalex   +1 more source

Prophylactic mastectomy and occult malignancy: Surgical and imaging considerations

Journal of Surgical Oncology, Volume 127, Issue 1, Page 18-27, January 2023., 2023
Abstract Background Sentinel node biopsy (SLNB) is not routinely recommended for patients undergoing prophylactic mastectomy (PM), yet omission remains a subject of debate among surgeons. A modern patient cohort was examined to determine occult malignancy (OM) incidence within PM specimens to reinforce current recommendations.
Jessica L. Thompson, Brandy R. Sinco, Rachel L. McCaffrey, Alfred E. Chang, Michael S. Sabel, Lesly A. Dossett, Tasha M. Hughes, Jacqueline S. Jeruss   +7 more
wiley   +1 more source

A unique case of pulmonary minimally invasive mucinous adenocarcinoma arising from atypical goblet cell hyperplasia in the bronchial epithelium of a 9-year-old girl. [PDF]

BMC Pediatr
Zhou P, Zhaxi C, Jiang L.
europepmc   +1 more source

A Syndrome of Multiorgan Hyperplasia with Features of Gigantism, Tumorigenesis, and Female Sterility in p27 Kip1 -Deficient Mice

Cell, 1996
M. Fero, Mick Rivkin, M. Tasch, P. Porter, C. Carow, E. Firpo, K. Polyak, L. Tsai, V. Broudy, R. Perlmutter, K. Kaushansky, James M. Roberts   +11 more
semanticscholar   +1 more source

Aldosterone excretion in normal children and in children with adrenal hyperplasia. [PDF]

, 1966
Maria I. New, Barbara Stoler Miller, Ralph E. Peterson   +2 more
openalex   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Endometrial histological patterns and associated factors of abnormal uterine bleeding among women seeking gynecological services from referral hospitals in Western Uganda: a cross-sectional study. [PDF]

BMC Womens Health
Logose J, Sabine Ishimwe MP, Kabali M, Okurut E, Eliu E, Ddamulira A, Hakizimana T.   +6 more
europepmc   +1 more source